FDA Outlines Policy for Overseeing Nanotechnology

The FDA suggests businesses to consult with them before launching nanotechnology products, but won’t make a judgment call in general on the technology.

Federal regulators want to hear from companies using tiny, engineered micro-particles in their products, part of an effort to stay abreast of the growing field of nanotechnology.

FDA Outlines Policy for Overseeing Nanotechnology | Inc.com.

 

Advertisements